Cardinal Therapeutics Inc Menlo Park, CA - 94025

Cardinal Therapeutics Inc is categorized under Biological Products Manufacturers in Menlo Park, CA and active since 2008.

Cardinal Therapeutics Inc was established in 2008, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Biological Products Manufacturers business, which does work in the B2B market, and is classified as a Biological Products Manufacturers, under code number 325414 by the NAICS.

If you are seeking more information, feel free to contact Hideki Garren at the company’s single location by writing to 830 Menlo Avenue # 105, Menlo Park, California CA 94025 or by phoning (650) 283-5816. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Cardinal Therapeutics Inc
Contact Person: Hideki Garren
Address: 830 Menlo Avenue # 105, Menlo Park, California 94025
Phone Number: (650) 283-5816
Annual Revenue (USD): $50.000 to $99.999
Founded: 2008
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Biological Products Manufacturers
SIC Code: 2836
NAICS Code: 325414
Share This Business:

Cardinal Therapeutics Inc was started in 2008 to provide professional Biological Products Manufacturers under the SIC code 2836 and NAICS code 325414. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.

Feel free to contact Hideki Garren for inquiries that concern Cardinal Therapeutics Inc by calling the company number (650) 283-5816, as your correspondence is most welcome. Additionally, the physical location of the single location of Cardinal Therapeutics Inc can be found at the coordinates 37.449709,-122.184671 as well as the street address 830 Menlo Avenue # 105 in Menlo Park, California 94025.

For its online presence, you may visit Cardinal Therapeutics Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.